Back to search

United Kingdom· GB-APID-35321811000001105

Vinblastine 8.2mg/50ml in Sodium chloride 0.9% infusion bags

A vinblastine product containing vinblastine, registered in United Kingdom by Special Order. The same ATC class is registered in 14 of our 19 countries.

ATC L01CA01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedVinblastine 8.2mg/50ml in Sodium chlo…ATCL01CA01REGISTER NO.GB-APID-3532181100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Vinblastine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01CA01 (vinblastine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Vinblastine · ATC L01CA01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vinblastine costs, country by country.

Normalised to the WHO defined daily dose (11.61 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vinblastine · price per daily dose (11.61 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$56.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Vinblastine
Manufacturer
Special Order
Country
United Kingdom (GB)
ATC code
L01CA01
ATC class
Vinblastine
Defined daily dose
11.61 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5051841050957

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

416 interactions on record for vinblastine.

Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vinblastine · interactions on record

416 records

  • 61 severe
  • 303 moderate
  • 24 minor
  • 28 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vinblastine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vinblastine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Velbe
  • Belgium · Vinblastine Teva
  • Czechia · Vinblastin Teva
  • Germany · Vinblastin Stada, Vinblastinsulfat Teva
  • Denmark · Velbe
  • Estonia · Vinblastine Teva
  • Spain · Vinblastina Stada
  • Finland · Velbe
  • France · Velbe
  • Ireland · Vinblastine Sulfate Pfizer Healthcare Ireland
  • Italy · Velbe
  • Lithuania · Vinblastine Teva
  • Luxembourg · Vinblastine Teva
  • Latvia · Vinblastine Teva
  • Malta · Vinblastine Sulfate Pfizer Hellas
  • Netherlands · Vinblastinesulfaat Pch
  • Norway · Velbe
  • Portugal · Solblastin
  • Romania · Vinblastină Teva
  • Sweden · Velbe

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5d2e0a3-c816-47ff-94b7-8b1d2abf33e6
GET /v1/drugs/f5d2e0a3-c816-47ff-94b7-8b1d2abf33e6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "35321811000001105",
  "desc": "Vinblastine 8.2mg/50ml in Sodium chloride 0.9% infusion bags (Special Order)",
  "form": "Infusion",
  "vpid": "35321711000001102",
  "source": "dmd",
  "vtm_id": "777936004",
  "strength": "164 microgram",
  "substance": "Vinblastine",
  "ingredient": "Vinblastine sulfate",
  "supplier_code": "8286711000001104"
}

See everything about vinblastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.